AI assistant
Sending…
Surrozen, Inc./DE — Director's Dealing 2020
Nov 19, 2020
34164_dirs_2020-11-18_18e41ec8-afa5-413b-9960-74a4f238f71f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Consonance-HFW Acquisition Corp. (CHFW)
CIK: 0001824893
Period of Report: 2020-11-18
Reporting Person: Consonance Life Sciences (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Class B Ordinary Shares | $ | Class A Ordinary Shares (2300000) | Direct |
Footnotes
F1: The shares will automatically convert into Class A ordinary Shares at the time of the Issuer's initial business combination.
F2: The shares owned by the Reporting Person include up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise in full their over-allotment as described in the Issuer's registration statement.
More from Surrozen, Inc./DE
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Director's Dealing
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18